Praluent (Alirocumab)

Praluent Information:

Buy Praluent

Praluent (Alirocumab) is used along with other medications and dietary/lifestyle changes to reduce the levels of low-density lipoprotein (LDL) (bad cholesterol) in individuals with hyperlipidemia. It is also used to reduce the risk of cardiovascular diseases such as heart attack and stroke. The active ingredient, Alirocumab, belongs to a class of drugs known as PCSK9 inhibitors. PCSK9 inhibitors like Praluent work by binding to PCSK9, preventing it from breaking down receptors on the liver cells responsible for removing LDL cholesterol from the bloodstream. By inhibiting PCSK9, Praluent increases the number of available receptors, enhancing the liver's ability to clear LDL cholesterol. This process helps lower LDL cholesterol levels and reduces the risk of cardiovascular events associated with high cholesterol.

Generic Praluent from Canada

Canada Drugs Online is proud to serve you the brand Praluent from Canada manufactured by Sanofi Aventis (LOCAL PICKUP ONLY). The generic Alirocumab is currently not available. Please call us toll-free at 1-877-900-3784 for details.

CanadaDrugsOnline.com also carries other Cholesterol medications such as Bezalip and Nexlizet.

Praluent Side Effects:

Common mild side effects of this medication include tiredness, sore throat, nasal congestion, redness, itching, swelling, or pain at the injection site. Contact your doctor if these mild side effects persist or worsen.

Possible serious side effects of this medication include drowsiness, bone pain, easily broken bones, fainting, severe body itching, rash, swelling of your face, lips, tongue, or throat, difficulty breathing, and dizziness. Discontinue this medication and seek immediate medical attention if you observe these severe side effects. Additionally, inform your doctor about any other side effects not listed here.

Clinical trials have shown that Praluent (Alirocumab) is effective in significantly reducing LDL cholesterol levels and reducing the risk of cardiovascular diseases by increasing the levels of good cholesterol (HDL-C). It has demonstrated good safety profile in these trials, with common side effects being injection site reactions and cold-like symptoms. However, individual responses may vary, and it's important for patients to discuss potential risks and benefits with their healthcare provider based on their specific health condition and medical history. The half-life of Alirocumab is approximately 17 to 20 days.

Praluent Directions:

This medication is available as a pre-filled pen containing a solution, which is to be injected under the skin of the thigh, abdomen, or upper arm by a qualified medical practitioner. If you are injecting this medication yourself, your doctor will show you how to use it properly. Check the leaflet in the medication pack for more usage instructions. Use this medication as prescribed by your doctor, and do not use more than the prescribed dose. Store this medication in the refrigerator and keep it away from children and pets. Do not freeze this medication. Allow the medication to warm to room temperature for 30 to 40 minutes before you inject it. Once it is removed from the refrigerator, it must be used within 24 hours and must not be put back into the refrigerator.

Praluent Precautions:

Before using this medication, ensure that you inform your doctor about any prior or current medical conditions, especially an allergic reaction to Alirocumab, other ingredients of Praluent, or any other medication. Do not use this medication during pregnancy or while breastfeeding unless recommended by your doctor. This medication is not recommended for use in individuals younger than 18 years. Some medications may interact with Alirocumab, affecting the way it works in the body. Therefore, make sure you inform your doctor about all the medications, including herbal medications and supplements you are taking before starting Praluent to prevent drug interactions.